Despite being a first-line treatment for CHE, nearly 40% of patients treated with TCS had inadequate treatment response or contraindications to TCS.
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...
New results from Eli Lilly and Company and Incyte showed once-daily, oral baricitinib 4 mg helped the majority of adolescent ...
The candidates who wish to apply for the various teaching and non-teaching posts at EMRS can refer to the official notification for the detailed educational qualifications for the posts of Prinicipal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback